BACKGROUND: Literature indicates a relationship between selenium supplementation and risk of diabetes. However, because these data are inconclusive, we investigated the effect of selenium supplementation on serum glucose levels in men with prostate cancer enrolled in a clinical trial testing of the effect of selenium on prostate cancer progression. METHODS: Subjects were randomized to receive placebo (n=46), selenium 200 microg/day (n=47), and selenium 800 microg/day (n=47). Serum glucose levels were obtained every 6 months for up to 5 years. Longitudinal analysis was carried out to assess whether rate of change of serum glucose levels was significantly different in the selenium-supplemented groups as compared with placebo. Sensitivity analyses were performed to assess the robustness of findings. RESULTS: Changes in serum glucose levels during the course of the trial were not statistically significantly different as compared with placebo for the selenium 200 microg/day (P=.56) or selenium 800 microg/day (P=.91) treatment groups. CONCLUSION: These results do not support a relationship between selenium supplementation and changes in serum glucose levels. Recommendations about selenium supplementation and risk of diabetes will require more definitive studies. Copyright 2010 Elsevier Inc. All rights reserved.
RCT Entities:
BACKGROUND: Literature indicates a relationship between selenium supplementation and risk of diabetes. However, because these data are inconclusive, we investigated the effect of selenium supplementation on serum glucose levels in men with prostate cancer enrolled in a clinical trial testing of the effect of selenium on prostate cancer progression. METHODS: Subjects were randomized to receive placebo (n=46), selenium 200 microg/day (n=47), and selenium 800 microg/day (n=47). Serum glucose levels were obtained every 6 months for up to 5 years. Longitudinal analysis was carried out to assess whether rate of change of serum glucose levels was significantly different in the selenium-supplemented groups as compared with placebo. Sensitivity analyses were performed to assess the robustness of findings. RESULTS: Changes in serum glucose levels during the course of the trial were not statistically significantly different as compared with placebo for the selenium 200 microg/day (P=.56) or selenium 800 microg/day (P=.91) treatment groups. CONCLUSION: These results do not support a relationship between selenium supplementation and changes in serum glucose levels. Recommendations about selenium supplementation and risk of diabetes will require more definitive studies. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: L C Clark; G F Combs; B W Turnbull; E H Slate; D K Chalker; J Chow; L S Davis; R A Glover; G F Graham; E G Gross; A Krongrad; J L Lesher; H K Park; B B Sanders; C L Smith; J R Taylor Journal: JAMA Date: 1996-12-25 Impact factor: 56.272
Authors: M S Stratton; M E Reid; G Schwartzberg; F E Minter; B K Monroe; D S Alberts; J R Marshall; F R Ahmann Journal: Anticancer Drugs Date: 2003-09 Impact factor: 2.248
Authors: A J Duffield-Lillico; B L Dalkin; M E Reid; B W Turnbull; E H Slate; E T Jacobs; J R Marshall; L C Clark Journal: BJU Int Date: 2003-05 Impact factor: 5.588
Authors: Mikhail Kosiborod; Silvio E Inzucchi; Abhinav Goyal; Harlan M Krumholz; Frederick A Masoudi; Lan Xiao; John A Spertus Journal: JAMA Date: 2009-04-15 Impact factor: 56.272
Authors: Saverio Stranges; James R Marshall; Raj Natarajan; Richard P Donahue; Maurizio Trevisan; Gerald F Combs; Francesco P Cappuccio; Antonio Ceriello; Mary E Reid Journal: Ann Intern Med Date: 2007-07-09 Impact factor: 25.391
Authors: L C Clark; B Dalkin; A Krongrad; G F Combs; B W Turnbull; E H Slate; R Witherington; J H Herlong; E Janosko; D Carpenter; C Borosso; S Falk; J Rounder Journal: Br J Urol Date: 1998-05
Authors: Scott M Lippman; Eric A Klein; Phyllis J Goodman; M Scott Lucia; Ian M Thompson; Leslie G Ford; Howard L Parnes; Lori M Minasian; J Michael Gaziano; Jo Ann Hartline; J Kellogg Parsons; James D Bearden; E David Crawford; Gary E Goodman; Jaime Claudio; Eric Winquist; Elise D Cook; Daniel D Karp; Philip Walther; Michael M Lieber; Alan R Kristal; Amy K Darke; Kathryn B Arnold; Patricia A Ganz; Regina M Santella; Demetrius Albanes; Philip R Taylor; Jeffrey L Probstfield; T J Jagpal; John J Crowley; Frank L Meyskens; Laurence H Baker; Charles A Coltman Journal: JAMA Date: 2008-12-09 Impact factor: 56.272
Authors: Maria E Goossens; Frank Buntinx; Steven Joniau; Koen Ackaert; Filip Ameye; Ignace Billiet; Johan Braeckman; Alex Breugelmans; Jochen Darras; Kurt Dilen; Lieven Goeman; Eliane Kellen; Bertrand Tombal; Siska Van Bruwaene; Ben Van Cleyenbreuge; Frank Van der Aa; Kris Vekemans; Hendrik Van Poppel; Maurice P Zeegers Journal: BMC Urol Date: 2012-03-21 Impact factor: 2.264
Authors: Andrea Dueregger; Isabel Heidegger; Philipp Ofer; Bernhard Perktold; Reinhold Ramoner; Helmut Klocker; Iris E Eder Journal: Nutrients Date: 2014-10-21 Impact factor: 5.717
Authors: Ewa Jablonska; Edyta Reszka; Jolanta Gromadzinska; Edyta Wieczorek; Magdalena B Krol; Sara Raimondi; Katarzyna Socha; Maria H Borawska; Wojciech Wasowicz Journal: Nutrients Date: 2016-12-13 Impact factor: 5.717